Unibest
← Back to patent-cliff list

CAS 1354691-72-7

tert-butyl (S)-3-((5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4-yl)amino)pyrrolidine-1-carboxylate

Codes: LENI-004

Application context (from source-drug indications)

原发性免疫缺陷疾病Leniolisib phosphatePI3Kδ过度活化综合征Leniolisib phosphate盆腔炎性疾病Leniolisib phosphate普通可变性免疫缺陷Leniolisib phosphate免疫缺陷性疾病Leniolisib phosphateSjögren's syndromeLeniolisib phosphate

Source drugs (routes using this intermediate)

DrugTierExpiry
Leniolisib phosphateTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.